Haemostasis and Tranexamic Acid in Caesarean Delivery

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

January 17, 2020

Study Completion Date

January 17, 2020

Conditions
Postpartum HemorrhageHyperfibrinolysis
Interventions
DIAGNOSTIC_TEST

peripartum haemostasis

Three blood samples of 20 ml each at T0 after the anaesthesia for the caesarean section and before the administration of the product (TXA or placebo), T15 fifteen minutes after the administration of the product and T120, 2 hours after the administration of the product.

Trial Locations (1)

33000

CHU Bordeaux, Bordeaux

All Listed Sponsors
collaborator

Bordeaux Association for Training and Research in Obstetric Gynecology

UNKNOWN

collaborator

Association of Anesthesiologists and Intensivists of Vascular Surgery and Transplantation

UNKNOWN

lead

University Hospital, Bordeaux

OTHER

NCT03742947 - Haemostasis and Tranexamic Acid in Caesarean Delivery | Biotech Hunter | Biotech Hunter